Orthopedic Biomaterial Market Insights: Growth Factors and Challenges
Viscosupplementation and the Biomaterial Landscape
While often overshadowed by joint replacements, viscosupplementation is a critical and growing part of the Orthopedic Biomaterial Market. The role of viscosupplementation is highlighted in a report on the Orthopedic Biomaterial Market. This procedure involves injecting a biomaterial, typically hyaluronic acid, into the knee joint to supplement the natural synovial fluid. It is a non-surgical option for patients with osteoarthritis to reduce pain and improve joint function. The market for viscosupplementation is driven by the desire for less invasive treatments and the high prevalence of knee osteoarthritis.
This segment is characterized by a variety of products with different injection cycles (single, two, three, or five) to suit patient needs. The discussion often centers on the efficacy of these treatments, their cost-effectiveness compared to surgery, and the ongoing development of more durable and effective viscosupplementation products.

